While systemic therapies like deucravacitinib have previously only been recommended for patients with moderate-to-severe plague psoriasis, it may be worth questioning whether body surface area alone is enough to dictate its use. Learn when scalp psoriasis may call for systemic therapies with Dr. Andrew Blauvelt, a dermatologist and clinical researcher with a focus on innovative treatments for psoriasis.